Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
STOK
Stock Latest News
The Fly
Stoke, Biogen announce data from open-label extension studies of zorevunersen
25d ago
BIIB
STOK
Premium
The Fly
Biogen, Stoke presents data from Phase 1/2a, OLE studies of zorevunersen
25d ago
BIIB
STOK
Premium
Ratings
Promising Potential of Stoke Therapeutics: Buy Rating Supported by Positive Zorevunersen Data and Strategic Advancements
1M ago
STOK
Premium
The Fly
Biogen, Stoke Therapeutics present data from studies of zorevunersen
1M ago
BIIB
STOK
Premium
The Fly
Stoke Therapeutics price target lowered to $28 from $29 at BTIG
1M ago
STOK
Premium
Ratings
Stoke Therapeutics: Promising Outlook with Strong Financial Position and Advancing Clinical Trials Justifies Buy Rating
2M ago
STOK
Premium
Ratings
Promising Developments in Stoke Therapeutics’ Clinical Trials Support Buy Rating
2M ago
STOK
Premium
Ratings
Positive Outlook for Stoke Therapeutics: Promising Clinical Data and Strong Financial Position
2M ago
STOK
Premium
Company Announcements
Stoke Therapeutics Advances RNA Medicine with Strong Q2 Results
2M ago
STOK
Premium
The Fly
Stoke Therapeutics reports Q2 EPS (40c), consensus (54c)
2M ago
STOK
Premium
The Fly
Stoke Therapeutics, Biogen announce first patient dosed in EMPEROR study
2M ago
BIIB
STOK
Premium
The Fly
Biogen, Stoke announce first patient dosed in Phase 3 EMPEROR study
2M ago
BIIB
STOK
Premium
Pre-Earnings
STOK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
STOK
Premium
The Fly
Stoke Therapeutics initiated with a Buy at Jefferies
2M ago
STOK
Premium
Company Announcements
Stoke Therapeutics’ EMPEROR Study: A New Hope for Dravet Syndrome
2M ago
STOK
Premium
Ratings
Buy Rating for Stoke Therapeutics: Promising Dravet Syndrome Treatment Shows Significant Improvements
3M ago
STOK
Premium
The Fly
Stoke Therapeutics, Biogen present data from EMPEROR study
3M ago
BIIB
STOK
Premium
The Fly
Biogen, Stoke Therapeutics present data from studies of zorevunersen
3M ago
BIIB
STOK
Premium
The Fly
Stoke Therapeutics files $400M mixed securities shelf
3M ago
STOK
Premium
Ratings
Positive Outlook on Stoke Therapeutics: Buy Rating Affirmed Amid Promising Phase 3 Trial for Dravet Syndrome Treatment
3M ago
STOK
Premium
Company Announcements
Stoke Therapeutics Advances Phase 3 Study for Dravet Syndrome Treatment
3M ago
STOK
Premium
Company Announcements
Stoke Therapeutics Adopts Key Proposals at Annual Meeting
4M ago
8K
STOK
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
